Methods for diagnosing and treating inflammatory bowel disease
US10669587B2 · kind B2 · utility
5Cited by
13References
26Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 7, 2019 |
| Grant date | Jun 2, 2020 |
| Priority date | — |
| Expiry date | Mar 7, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2600/158
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
Biomarkers predictive of responsiveness to integrin beta7 antagonists, including anti-beta7 integrin subunit antibodies, and methods of using such biomarkers are provided. In addition, methods of treating gastrointestinal inflammatory disorders such as inflammatory bowel diseases including ulcerative colitis and Crohn's disease are provided. Also provided are methods of using such predictive biomarkers for the treatment of inflammatory bowel diseases including ulcerative colitis and Crohn's disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.